Published in Exp Hematol on October 01, 1987
Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol (2010) 1.67
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J Natl Cancer Inst (1980) 1.53
Interleukin-6 release following scorpion sting in children. Toxicon (1996) 1.48
Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Isr J Med Sci (1992) 1.39
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs. Isr J Med Sci (1991) 1.38
The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases. Br J Haematol (1980) 1.34
Genetic control of lipopolysaccharide induced generation of serum colony stimulating factor and proliferation of splenic granulocyte/macrophage precursor cells. J Cell Physiol (1976) 1.28
Increasing empathy among medical students. Med Educ (1989) 1.27
Increased risk of cancer in patients with Gaucher disease. Cancer (1993) 1.20
T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor. Nature (1980) 1.19
Cytokine involvement in oocytes and early embryos. Fertil Steril (1991) 1.18
Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells. J Cell Physiol (1976) 1.17
Incidence, prognostic significance and therapeutic modalities of central nervous system involvement in multiple myeloma. Acta Haematol (1982) 1.10
A new cryosurgical device for controlled freezing. Cryobiology (1996) 1.10
Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Br J Haematol (1988) 1.04
Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem Biophys Res Commun (1989) 1.03
Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest (1988) 1.02
Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis. Mol Cell Biol (1988) 0.99
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Cancer Res (1999) 0.97
Cardiac involvement in patients with myeloproliferative disorders. Am J Med (1992) 0.96
Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase. EMBO J (1994) 0.95
Distinct patterns of IL-1 alpha and IL-1 beta organ distribution--a possible basis for organ mechanisms of innate immunity. Adv Exp Med Biol (2000) 0.95
Extinction of expression of immunoglobulin genes in myeloma X fibroblast somatic cell hybrids. Mol Cell Biol (1987) 0.95
Impact of workshop on students' and physicians' rejecting behaviors in patient interviews. J Med Educ (1987) 0.94
Regulation of interleukin 1 generation in immune-activated fibroblasts. Eur J Immunol (1990) 0.93
Control mechanisms of endotoxin and particulate material stimulation of hemopoietic colony forming cell differentiation. Exp Hematol (1976) 0.92
Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer. Int J Cancer (1992) 0.92
Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J Immunol (1977) 0.91
Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer (1978) 0.91
Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. J Immunol (1988) 0.90
Prognostic significance of plasma cell morphology in multiple myeloma. Cancer (1987) 0.90
ASdult Fanconi's syndrome with renal tubular acidosis in association with renal amyloidosis: occurrence in a patient with chronic lymphocytic leukemia. Arch Intern Med (1980) 0.89
Proof of in vivo fusion of murine tumor cells with host cells by universal fusers. J Natl Cancer Inst (1978) 0.87
Gastrointestinal bleeding in von Willebrand's disease. Case report with discussion of the diagnostic and therapeutic problems involved. Arch Intern Med (1966) 0.87
The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma. Br J Haematol (1990) 0.87
Different regulatory levels are involved in the generation of hemopoietic cytokines (CSFs and IL-6) in fibroblasts stimulated by inflammatory products. Cytokine (1993) 0.86
Pancoast's syndrome in multiple myeloma. Acta Haematol (1984) 0.86
Ureaplasma urealyticum in Reiter's syndrome. J Rheumatol (1994) 0.85
Establishment and characterization of continuous helper T cell lines specific to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys). J Immunol (1981) 0.85
Hereditary deficiency of all vitamin K-dependent procoagulants and anticoagulants. Br J Haematol (1990) 0.85
Regulation of lipopolysaccharide-induced granulopoiesis and macrophage formation by spleen cells. II. Macrophage-lymphocyte interactions in the process of generation of colony-stimulating factor. J Immunol (1980) 0.85
High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. Leuk Lymphoma (1992) 0.84
An evaluation of the short-term effects of an interpersonal skills course. Med Educ (1984) 0.84
Regulation of lipopolysaccharide-induced granulopoiesis and macrophage formation by spleen cells. I. Relationship between colony-stimulating factor release and lymphocyte activation in vitro. J Immunol (1977) 0.84
Partial purification and characterization of an antigen-specific helper factor synthesized by a T-cell continuous line. Proc Natl Acad Sci U S A (1983) 0.83
[Conservative treatment of hemophiliac bleeding]. Harefuah (1990) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis. Cancer (1987) 0.83
Characteristics of a poly(LTyr,LGlu)-poly(DLAla)--poly(LLys)-specific helper factor derived from a T cell hybridoma. Eur J Immunol (1981) 0.83
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst (1982) 0.83
Increased low-density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci (1986) 0.83
Serum haptoglobin types and leukemia. Hum Genet (1986) 0.82
Cell cycle events in the hydrocortisone regulation of alkaline phosphatase in HeLa S3 cells. J Cell Biol (1969) 0.82
Successful treatment of post-partum renal failure with heparin. Br Med J (1970) 0.81
Impaired immunoglobulin synthesis in multiple myeloma: a B-cell dysfunction. Am J Hematol (1986) 0.81
Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Exp Hematol (1986) 0.81
Generation of colony-stimulating factor by purified macrophages and lymphocytes. J Reticuloendothel Soc (1979) 0.80
Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3. Br J Haematol (1987) 0.80
Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men. J Nucl Med (1990) 0.80
Macrophages as regulators of granulopoiesis. Adv Exp Med Biol (1979) 0.80
Nature and function of antigen-specific T-cell lines and their products. Physiol Rev (1986) 0.80
Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity. Eur Cytokine Netw (1992) 0.80
Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II. J Clin Endocrinol Metab (1992) 0.80
Autoimmune hemolytic anemia in the course of Kaposi's sarcoma--report of a case. Cancer (1973) 0.79
Extinction of expression of the translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells. Int J Cancer (1989) 0.79
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. J Natl Cancer Inst (1982) 0.79
Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol (1994) 0.79
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. Acta Haematol (1985) 0.79
Chemiluminescence response of polymorphonuclear leucocytes to serum-opsonized zymosan--a predictive parameter for infections and prognosis in multiple myeloma patients. Clin Lab Haematol (1988) 0.79
Expression of PKCeta in NIH-3T3 cells promotes production of the pro-inflammatory cytokine interleukin-6. Eur Cytokine Netw (1999) 0.79
Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV). Clin Exp Immunol (1987) 0.79
Analysis of the fine antigenic specificity of the (T,G)-A--L specific helper T cell continuous line E-9M(+). J Immunol (1982) 0.79
Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres. Cytokine (2000) 0.79
Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells. Ann Hum Genet (1981) 0.78
Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases. Oncology (1984) 0.78
Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid. J Natl Cancer Inst (1982) 0.78
Prolonged remission of leukemia associated with polycythemia vera. Cancer (1977) 0.78
Mycoplasma-induced in vitro production of interleukin-2 and colony-stimulating activity. Isr J Med Sci (1987) 0.78
Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumor response. Int J Cancer (1992) 0.78
Significance of multiple types of antibodies on red blood cells of patients with positive direct antiglobulin test: a study of monospecific antiglobulin reactions in 85 patients. Scand J Haematol (1985) 0.78
The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His). Thromb Haemost (1989) 0.78
Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS-injected mice. Cytokine (1996) 0.78
Membrane-bound and cellular immunoglobulins in human B-lymphoma lines and derived hybrids. Immunobiology (1981) 0.77
Direct involvement of spectrin thiols in maintaining erythrocyte membrane thermal stability and spectrin dimer self-association. Biochim Biophys Acta (1988) 0.77
Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features. Eur Cytokine Netw (1996) 0.77
Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. Acta Haematol (1986) 0.77
Use of isolated mitochondria to transfer chloramphenicol resistance in hamster cells. Isr J Med Sci (1984) 0.77
Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors. Leukemia (1991) 0.77
The teaching of history-taking and diagnostic thinking: description of a method. Med Educ (1981) 0.77
Effect of cytosine arabinoside on differentiation of normal human bone marrow cells. Exp Hematol (1986) 0.77
Interleukin-1 produced by tumorigenic fibroblasts influences tumor rejection. Int J Cancer (1992) 0.76
Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating cultures. J Natl Cancer Inst (1984) 0.76
Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia. Am J Hematol (1992) 0.76
Prophylaxis of thromboembolism during pregnancy in hereditary AT-III deficiency. Am J Hematol (1992) 0.76
Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT). Eur J Cancer (1979) 0.76
Carbamazepine (Tegretol)-induced thrombocytopenia. Vox Sang (1993) 0.76
Depressed IL-1 production by chronic GVHD dermal fibroblasts. Eur Cytokine Netw (1991) 0.76
Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Int J Cancer (1978) 0.76
Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somat Cell Mol Genet (1996) 0.76